No products in the cart.
Lipaglyn 4 mg (Saroglitazar)
Lipaglyn 4 mg contains Saroglitazar, a dual-action medicine for diabetic dyslipidemia and hypertriglyceridemia in type 2 diabetes patients.
Lipaglyn 4 mg (Saroglitazar)
| Active Ingredient | Saroglitazar |
|---|---|
| Indication: | Non-alcoholic Fatty Liver Disease |
| Manufacturer: | Zydus Lifesciences |
| Packaging | 15 Tablets in strip |
| Strength | 4mg |
| Delivery Time | 6 To 15 days |
Lipaglyn 4 mg contains Saroglitazar, a novel dual PPAR α/γ agonist developed specifically for the treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes mellitus (T2DM). It helps regulate lipid and glucose metabolism, making it an effective therapy for managing both high triglycerides and blood sugar levels simultaneously.
Saroglitazar lowers serum triglycerides, LDL cholesterol, and HbA1c, while also improving insulin sensitivity. It is especially beneficial for patients who do not achieve adequate lipid control with statins alone.
Lipaglyn 4 mg tablets are taken orally once daily and are well-tolerated, with a low incidence of weight gain or hypoglycemia. This makes it a valuable option for patients with diabetic dyslipidemia and metabolic syndrome
| pack size | 50 Tablets – USD $1.10 Per Tablet, 100 Tablets – USD $0.90 Per Tablet, 150 Tablets – USD $0.85 Per Tablet |
|---|
Be the first to review “Lipaglyn 4 mg (Saroglitazar)”
You must be logged in to post a review.
Related Products
Buy Dexona 0.5mg (Dexamethasone)
Price range: $9.00 through $25.00
Buy Belustine 40 Mg (Lomustine)
Price range: $40.00 through $95.00
Buy Anabrez 1Mg (Anastrozole)
Price range: $50.00 through $145.00
Buy Capegard 500 Mg (Capecitabine)
Price range: $285.00 through $930.00
There are no reviews yet.